Coyote Completes Series B Financing, CEC Capital Served as Exclusive Financial Advisor


Coyote Bioscience, a leading molecular diagnosis company in China, announced today that it had completed Series B financing.  The round was led by Northern Light Ventures, with participation from SAIF Asia and Legend Star.
CEC Capital served as the exclusive financial advisor to Coyote in this transaction.

Media Contacts